This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States.
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
The Company develops professional medical devices and innovative cosmeceuticals in the field of aesthetic medicine since the beginning of 2000s, with constantly growing turnover.
The company has patented a line of professional products for chemical peeling that provides the medical class with an innovative technology for personalised treatments and easier , safer use. This includes the development of a very high molecular weight hyaluronic acid for biostimulation treatments, and a home care line with cosmeceutical products based on modern knowledge of biochemistry, biology and medicine
Company’s mission is to provide aesthetic specialists with the necessary tools to promote the well-being of the skin and body with skin rejuvenation actions. To this day, it has signed distribution agreements with foreign companies leading their research, development and marketing of innovative medical devices. By all that, the company holds an important market share of the Italian market.
Over the years the company has built an excellent brand name in the field of aesthetic medicine thanks to the quality and innovation of its products and management.
It operates throughout the country by using a network of 15 single-agents, and distributes its products in the following sales channels:
Aesthetic Physicians and Aesthetic Clinics, Dermatologists and Plastic Surgeons.
Pharmaceutical wholesalers.
Pharmacies.
E-commerce for end consumers.
Company’s own brand products:
a line of medical peeling devices formulated using innovative patented technology.
a line of Cosmeceuticals products.
a line of injectable products based on hyaluronic acid with very high molecular weight, and biorevitalizing action.
Products through distribution agreements:
a line of injectable products based on hyaluronic acid and other components with filling function and biostimulation.
a line consisting of innovative injectables based on hyaluronic acid with advanced components of the new generation:
for body remodelling with lipolytic action.
for the reduction of bags under the eyes.
for aging and tear through.
for the skin pigmentation.
to block the fall and stimulate hair regrowth.
a line of bio restructuring and traction PDO threads, for face and body conveyed by Japanese patented needles.
a line of thin-walled needles and cannulas with Japanese patent.
The Company develops professional medical devices and innovative cosmeceuticals in the field of aesthetic medicine since the beginning of 2000s, with constantly growing turnover.
The company has patented a line of professional products for chemical peeling that provides the medical class with an innovative technology for personalised treatments and easier , safer use. This includes the development of a very high molecular weight hyaluronic acid for biostimulation treatments, and a home care line with cosmeceutical products based on modern knowledge of biochemistry, biology and medicine
Company’s mission is to provide aesthetic specialists with the necessary tools to promote the well-being of the skin and body with skin rejuvenation actions. To this day, it has signed distribution agreements with foreign companies leading their research, development and marketing of innovative medical devices. By all that, the company holds an important market share of the Italian market.
Over the years the company has built an excellent brand name in the field of aesthetic medicine thanks to the quality and innovation of its products and management.
It operates throughout the country by using a network of 15 single-agents, and distributes its products in the following sales channels:
Aesthetic Physicians and Aesthetic Clinics, Dermatologists and Plastic Surgeons.
Pharmaceutical wholesalers.
Pharmacies.
E-commerce for end consumers.
Company’s own brand products:
a line of medical peeling devices formulated using innovative patented technology.
a line of Cosmeceuticals products.
a line of injectable products based on hyaluronic acid with very high molecular weight, and biorevitalizing action.
Products through distribution agreements:
a line of injectable products based on hyaluronic acid and other components with filling function and biostimulation.
a line consisting of innovative injectables based on hyaluronic acid with advanced components of the new generation:
for body remodelling with lipolytic action.
for the reduction of bags under the eyes.
for aging and tear through.
for the skin pigmentation.
to block the fall and stimulate hair regrowth.
a line of bio restructuring and traction PDO threads, for face and body conveyed by Japanese patented needles.
a line of thin-walled needles and cannulas with Japanese patent.
Description
The Company develops professional medical devices and innovative cosmeceuticals in the field of aesthetic medicine since the beginning of 2000s, with constantly growing turnover.
The company has patented a line of professional products for chemical peeling that provides the medical class with an innovative technology for personalised treatments and easier , safer use. This includes the development of a very high molecular weight hyaluronic acid for biostimulation treatments, and a home care line with cosmeceutical products based on modern knowledge of biochemistry, biology and medicine
Company’s mission is to provide aesthetic specialists with the necessary tools to promote the well-being of the skin and body with skin rejuvenation actions. To this day, it has signed distribution agreements with foreign companies leading their research, development and marketing of innovative medical devices. By all that, the company holds an important market share of the Italian market.
Over the years the company has built an excellent brand name in the field of aesthetic medicine thanks to the quality and innovation of its products and management.
It operates throughout the country by using a network of 15 single-agents, and distributes its products in the following sales channels:
Company’s own brand products:
Basic Details
Target Price:
TBD
Gross Revenue
$7,454,467
EBITDA
$1,075,680
Business ID:
L#20240687
Country
Italy
Detail
PREVIOUS PROPERTY
Beauty and Pharmaceutical Testing Lab
NEXT PROPERTY
30 + Years Old Accredited Domain Names Registrant Business